Dementia outcomes after addition of proxy‐based assessments for deceased or proxy‐dependent participants

Objectives As people age and the incidence of dementia increases, studies of cognitive function continue to be of importance. Ascertaining cognitive data through different mechanisms is necessary to address missing data concerns. Methods The Dementia Questionnaire (DQ), which utilizes proxy‐based as...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of geriatric psychiatry 2019-10, Vol.34 (10), p.1403-1411
Hauptverfasser: Gaussoin, Sarah A., Espeland, Mark A., Beavers, Daniel P., Casanova, Ramon, Garcia, Katelyn R., Snively, Beverly M., Shumaker, Sally A., Wallace, Robert B., Rapp, Stephen R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1411
container_issue 10
container_start_page 1403
container_title International journal of geriatric psychiatry
container_volume 34
creator Gaussoin, Sarah A.
Espeland, Mark A.
Beavers, Daniel P.
Casanova, Ramon
Garcia, Katelyn R.
Snively, Beverly M.
Shumaker, Sally A.
Wallace, Robert B.
Rapp, Stephen R.
description Objectives As people age and the incidence of dementia increases, studies of cognitive function continue to be of importance. Ascertaining cognitive data through different mechanisms is necessary to address missing data concerns. Methods The Dementia Questionnaire (DQ), which utilizes proxy‐based assessments, is a potential tool to determine cognitive status in participants no longer being followed per traditional study protocol. The DQ is currently being used in the Supplemental Case Ascertainment Protocol (SCAP), which is being conducted in an ongoing study of postmenopausal women as part of the Women's Health Initiative Memory Study (WHIMS). Results Ninety‐four percent of the 1260 SCAP participants were eligible because of being deceased. Those who are SCAP eligible were older, were less likely to be a minority, and were more likely to have hypertension, diabetes, and prior history of cardiovascular disease (CVD) as well as being a past or current smoker. SCAP added 109 cases of probable dementia to WHIMS. Risk factor relationships were modified upon inclusion of the SCAP cases including an attenuation of a hormone therapy effect and discovery of a hypertension effect. Conclusions Augmenting clinic‐based cases with proxy‐based assessments is feasible and leads to increased incident cases of dementia. When planning future clinical trials, it may be of study benefit to include a protocol of proxy‐based assessments, develop strong relationships with proxies early on in the study, and attempt to maintain this relationship throughout the lifespan of the trial.
doi_str_mv 10.1002/gps.5130
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6742525</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2217492983</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4380-54bf942537b0b7a25de45b841a56e1d4b905c01261c48ff1fdd0fb710db7c9d03</originalsourceid><addsrcrecordid>eNp1kd1qFTEUhYMo9ngUfAIJeOPN1J1JMj83gtRahYKCeh3ys1NTZiZjMqM9dz6Cz-iTmPa09Qe8SmB9WXvtLEIeMzhkAPXzszkfSsbhDtkw6PuKsaa5SzbQdbJqag4H5EHO5wBFY919csAZcNG0zYYMr3DEaQmaxnWxccRMtV8wUe1cWEKcaPR0TvFi9_P7D6MzOqpzxpwvX2XqY6IOLV4J5X5DOpxxcgWhs05LsGHWBX9I7nk9ZHx0fW7Jp9fHH4_eVKfvTt4evTytrOAdVFIY34ta8taAaXUtHQppOsG0bJA5YXqQFljdMCs675l3DrxpGTjT2t4B35IXe995NSM6W3IkPag5hVGnnYo6qL-VKXxWZ_GratoytgzekmfXBil-WTEvagzZ4jDoCeOaVV2zVvR13_GCPv0HPY9rmsp6hSr_z6H08tvQpphzQn8bhoG6rFCVCpXco0_-DH8L3nRWgGoPfAsD7v5rpE7ef7gy_AWfDqm-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2288530130</pqid></control><display><type>article</type><title>Dementia outcomes after addition of proxy‐based assessments for deceased or proxy‐dependent participants</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Gaussoin, Sarah A. ; Espeland, Mark A. ; Beavers, Daniel P. ; Casanova, Ramon ; Garcia, Katelyn R. ; Snively, Beverly M. ; Shumaker, Sally A. ; Wallace, Robert B. ; Rapp, Stephen R.</creator><creatorcontrib>Gaussoin, Sarah A. ; Espeland, Mark A. ; Beavers, Daniel P. ; Casanova, Ramon ; Garcia, Katelyn R. ; Snively, Beverly M. ; Shumaker, Sally A. ; Wallace, Robert B. ; Rapp, Stephen R.</creatorcontrib><description>Objectives As people age and the incidence of dementia increases, studies of cognitive function continue to be of importance. Ascertaining cognitive data through different mechanisms is necessary to address missing data concerns. Methods The Dementia Questionnaire (DQ), which utilizes proxy‐based assessments, is a potential tool to determine cognitive status in participants no longer being followed per traditional study protocol. The DQ is currently being used in the Supplemental Case Ascertainment Protocol (SCAP), which is being conducted in an ongoing study of postmenopausal women as part of the Women's Health Initiative Memory Study (WHIMS). Results Ninety‐four percent of the 1260 SCAP participants were eligible because of being deceased. Those who are SCAP eligible were older, were less likely to be a minority, and were more likely to have hypertension, diabetes, and prior history of cardiovascular disease (CVD) as well as being a past or current smoker. SCAP added 109 cases of probable dementia to WHIMS. Risk factor relationships were modified upon inclusion of the SCAP cases including an attenuation of a hormone therapy effect and discovery of a hypertension effect. Conclusions Augmenting clinic‐based cases with proxy‐based assessments is feasible and leads to increased incident cases of dementia. When planning future clinical trials, it may be of study benefit to include a protocol of proxy‐based assessments, develop strong relationships with proxies early on in the study, and attempt to maintain this relationship throughout the lifespan of the trial.</description><identifier>ISSN: 0885-6230</identifier><identifier>EISSN: 1099-1166</identifier><identifier>DOI: 10.1002/gps.5130</identifier><identifier>PMID: 31034676</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Aged ; Cardiovascular diseases ; Clinical trials ; Cognition - drug effects ; Cognition - physiology ; Cognition Disorders - diagnosis ; Cognition Disorders - epidemiology ; Cognition Disorders - prevention &amp; control ; Cognitive ability ; cognitive aging ; Dementia ; Dementia - epidemiology ; Dementia disorders ; Diabetes mellitus ; Female ; Geriatric psychiatry ; Hormone replacement therapy ; Hormone Replacement Therapy - statistics &amp; numerical data ; Humans ; Hypertension ; Incidence ; Life span ; Menopause ; Middle Aged ; Missing data ; Post-menopause ; Risk Factors ; Surveys and Questionnaires - standards ; Womens health</subject><ispartof>International journal of geriatric psychiatry, 2019-10, Vol.34 (10), p.1403-1411</ispartof><rights>2019 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4380-54bf942537b0b7a25de45b841a56e1d4b905c01261c48ff1fdd0fb710db7c9d03</citedby><cites>FETCH-LOGICAL-c4380-54bf942537b0b7a25de45b841a56e1d4b905c01261c48ff1fdd0fb710db7c9d03</cites><orcidid>0000-0003-0850-7888</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fgps.5130$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fgps.5130$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31034676$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gaussoin, Sarah A.</creatorcontrib><creatorcontrib>Espeland, Mark A.</creatorcontrib><creatorcontrib>Beavers, Daniel P.</creatorcontrib><creatorcontrib>Casanova, Ramon</creatorcontrib><creatorcontrib>Garcia, Katelyn R.</creatorcontrib><creatorcontrib>Snively, Beverly M.</creatorcontrib><creatorcontrib>Shumaker, Sally A.</creatorcontrib><creatorcontrib>Wallace, Robert B.</creatorcontrib><creatorcontrib>Rapp, Stephen R.</creatorcontrib><title>Dementia outcomes after addition of proxy‐based assessments for deceased or proxy‐dependent participants</title><title>International journal of geriatric psychiatry</title><addtitle>Int J Geriatr Psychiatry</addtitle><description>Objectives As people age and the incidence of dementia increases, studies of cognitive function continue to be of importance. Ascertaining cognitive data through different mechanisms is necessary to address missing data concerns. Methods The Dementia Questionnaire (DQ), which utilizes proxy‐based assessments, is a potential tool to determine cognitive status in participants no longer being followed per traditional study protocol. The DQ is currently being used in the Supplemental Case Ascertainment Protocol (SCAP), which is being conducted in an ongoing study of postmenopausal women as part of the Women's Health Initiative Memory Study (WHIMS). Results Ninety‐four percent of the 1260 SCAP participants were eligible because of being deceased. Those who are SCAP eligible were older, were less likely to be a minority, and were more likely to have hypertension, diabetes, and prior history of cardiovascular disease (CVD) as well as being a past or current smoker. SCAP added 109 cases of probable dementia to WHIMS. Risk factor relationships were modified upon inclusion of the SCAP cases including an attenuation of a hormone therapy effect and discovery of a hypertension effect. Conclusions Augmenting clinic‐based cases with proxy‐based assessments is feasible and leads to increased incident cases of dementia. When planning future clinical trials, it may be of study benefit to include a protocol of proxy‐based assessments, develop strong relationships with proxies early on in the study, and attempt to maintain this relationship throughout the lifespan of the trial.</description><subject>Aged</subject><subject>Cardiovascular diseases</subject><subject>Clinical trials</subject><subject>Cognition - drug effects</subject><subject>Cognition - physiology</subject><subject>Cognition Disorders - diagnosis</subject><subject>Cognition Disorders - epidemiology</subject><subject>Cognition Disorders - prevention &amp; control</subject><subject>Cognitive ability</subject><subject>cognitive aging</subject><subject>Dementia</subject><subject>Dementia - epidemiology</subject><subject>Dementia disorders</subject><subject>Diabetes mellitus</subject><subject>Female</subject><subject>Geriatric psychiatry</subject><subject>Hormone replacement therapy</subject><subject>Hormone Replacement Therapy - statistics &amp; numerical data</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Incidence</subject><subject>Life span</subject><subject>Menopause</subject><subject>Middle Aged</subject><subject>Missing data</subject><subject>Post-menopause</subject><subject>Risk Factors</subject><subject>Surveys and Questionnaires - standards</subject><subject>Womens health</subject><issn>0885-6230</issn><issn>1099-1166</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kd1qFTEUhYMo9ngUfAIJeOPN1J1JMj83gtRahYKCeh3ys1NTZiZjMqM9dz6Cz-iTmPa09Qe8SmB9WXvtLEIeMzhkAPXzszkfSsbhDtkw6PuKsaa5SzbQdbJqag4H5EHO5wBFY919csAZcNG0zYYMr3DEaQmaxnWxccRMtV8wUe1cWEKcaPR0TvFi9_P7D6MzOqpzxpwvX2XqY6IOLV4J5X5DOpxxcgWhs05LsGHWBX9I7nk9ZHx0fW7Jp9fHH4_eVKfvTt4evTytrOAdVFIY34ta8taAaXUtHQppOsG0bJA5YXqQFljdMCs675l3DrxpGTjT2t4B35IXe995NSM6W3IkPag5hVGnnYo6qL-VKXxWZ_GratoytgzekmfXBil-WTEvagzZ4jDoCeOaVV2zVvR13_GCPv0HPY9rmsp6hSr_z6H08tvQpphzQn8bhoG6rFCVCpXco0_-DH8L3nRWgGoPfAsD7v5rpE7ef7gy_AWfDqm-</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Gaussoin, Sarah A.</creator><creator>Espeland, Mark A.</creator><creator>Beavers, Daniel P.</creator><creator>Casanova, Ramon</creator><creator>Garcia, Katelyn R.</creator><creator>Snively, Beverly M.</creator><creator>Shumaker, Sally A.</creator><creator>Wallace, Robert B.</creator><creator>Rapp, Stephen R.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0850-7888</orcidid></search><sort><creationdate>201910</creationdate><title>Dementia outcomes after addition of proxy‐based assessments for deceased or proxy‐dependent participants</title><author>Gaussoin, Sarah A. ; Espeland, Mark A. ; Beavers, Daniel P. ; Casanova, Ramon ; Garcia, Katelyn R. ; Snively, Beverly M. ; Shumaker, Sally A. ; Wallace, Robert B. ; Rapp, Stephen R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4380-54bf942537b0b7a25de45b841a56e1d4b905c01261c48ff1fdd0fb710db7c9d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Cardiovascular diseases</topic><topic>Clinical trials</topic><topic>Cognition - drug effects</topic><topic>Cognition - physiology</topic><topic>Cognition Disorders - diagnosis</topic><topic>Cognition Disorders - epidemiology</topic><topic>Cognition Disorders - prevention &amp; control</topic><topic>Cognitive ability</topic><topic>cognitive aging</topic><topic>Dementia</topic><topic>Dementia - epidemiology</topic><topic>Dementia disorders</topic><topic>Diabetes mellitus</topic><topic>Female</topic><topic>Geriatric psychiatry</topic><topic>Hormone replacement therapy</topic><topic>Hormone Replacement Therapy - statistics &amp; numerical data</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Incidence</topic><topic>Life span</topic><topic>Menopause</topic><topic>Middle Aged</topic><topic>Missing data</topic><topic>Post-menopause</topic><topic>Risk Factors</topic><topic>Surveys and Questionnaires - standards</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gaussoin, Sarah A.</creatorcontrib><creatorcontrib>Espeland, Mark A.</creatorcontrib><creatorcontrib>Beavers, Daniel P.</creatorcontrib><creatorcontrib>Casanova, Ramon</creatorcontrib><creatorcontrib>Garcia, Katelyn R.</creatorcontrib><creatorcontrib>Snively, Beverly M.</creatorcontrib><creatorcontrib>Shumaker, Sally A.</creatorcontrib><creatorcontrib>Wallace, Robert B.</creatorcontrib><creatorcontrib>Rapp, Stephen R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of geriatric psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gaussoin, Sarah A.</au><au>Espeland, Mark A.</au><au>Beavers, Daniel P.</au><au>Casanova, Ramon</au><au>Garcia, Katelyn R.</au><au>Snively, Beverly M.</au><au>Shumaker, Sally A.</au><au>Wallace, Robert B.</au><au>Rapp, Stephen R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dementia outcomes after addition of proxy‐based assessments for deceased or proxy‐dependent participants</atitle><jtitle>International journal of geriatric psychiatry</jtitle><addtitle>Int J Geriatr Psychiatry</addtitle><date>2019-10</date><risdate>2019</risdate><volume>34</volume><issue>10</issue><spage>1403</spage><epage>1411</epage><pages>1403-1411</pages><issn>0885-6230</issn><eissn>1099-1166</eissn><abstract>Objectives As people age and the incidence of dementia increases, studies of cognitive function continue to be of importance. Ascertaining cognitive data through different mechanisms is necessary to address missing data concerns. Methods The Dementia Questionnaire (DQ), which utilizes proxy‐based assessments, is a potential tool to determine cognitive status in participants no longer being followed per traditional study protocol. The DQ is currently being used in the Supplemental Case Ascertainment Protocol (SCAP), which is being conducted in an ongoing study of postmenopausal women as part of the Women's Health Initiative Memory Study (WHIMS). Results Ninety‐four percent of the 1260 SCAP participants were eligible because of being deceased. Those who are SCAP eligible were older, were less likely to be a minority, and were more likely to have hypertension, diabetes, and prior history of cardiovascular disease (CVD) as well as being a past or current smoker. SCAP added 109 cases of probable dementia to WHIMS. Risk factor relationships were modified upon inclusion of the SCAP cases including an attenuation of a hormone therapy effect and discovery of a hypertension effect. Conclusions Augmenting clinic‐based cases with proxy‐based assessments is feasible and leads to increased incident cases of dementia. When planning future clinical trials, it may be of study benefit to include a protocol of proxy‐based assessments, develop strong relationships with proxies early on in the study, and attempt to maintain this relationship throughout the lifespan of the trial.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31034676</pmid><doi>10.1002/gps.5130</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-0850-7888</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0885-6230
ispartof International journal of geriatric psychiatry, 2019-10, Vol.34 (10), p.1403-1411
issn 0885-6230
1099-1166
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6742525
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Aged
Cardiovascular diseases
Clinical trials
Cognition - drug effects
Cognition - physiology
Cognition Disorders - diagnosis
Cognition Disorders - epidemiology
Cognition Disorders - prevention & control
Cognitive ability
cognitive aging
Dementia
Dementia - epidemiology
Dementia disorders
Diabetes mellitus
Female
Geriatric psychiatry
Hormone replacement therapy
Hormone Replacement Therapy - statistics & numerical data
Humans
Hypertension
Incidence
Life span
Menopause
Middle Aged
Missing data
Post-menopause
Risk Factors
Surveys and Questionnaires - standards
Womens health
title Dementia outcomes after addition of proxy‐based assessments for deceased or proxy‐dependent participants
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T20%3A48%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dementia%20outcomes%20after%20addition%20of%20proxy%E2%80%90based%20assessments%20for%20deceased%20or%20proxy%E2%80%90dependent%20participants&rft.jtitle=International%20journal%20of%20geriatric%20psychiatry&rft.au=Gaussoin,%20Sarah%20A.&rft.date=2019-10&rft.volume=34&rft.issue=10&rft.spage=1403&rft.epage=1411&rft.pages=1403-1411&rft.issn=0885-6230&rft.eissn=1099-1166&rft_id=info:doi/10.1002/gps.5130&rft_dat=%3Cproquest_pubme%3E2217492983%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2288530130&rft_id=info:pmid/31034676&rfr_iscdi=true